Top Buy
| Security | Buy | Sell | Buy (1W) ▼ | Sell (1W) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Medtronic plc | 7 | 1 | 0 | 0 | €80.58 | €92.55 | 14.855% |
| Healthstream Inc. | 4 | 0 | 0 | 0 | €26.00 | €29.29 | 12.665% |
| Rewalk Robotics Ltd. | 1 | 7 | 0 | 0 | €5.00 | - | - |
| Akero Therapeutics Inc | 17 | 0 | 0 | 0 | €24.02 | €38.19 | 59.007% |
| Sanofi S.A. | 4 | 0 | 0 | 0 | €103.72 | €109.00 | 5.091% |
| Icu Medical Inc. | 6 | 0 | 0 | 0 | €149.00 | €139.70 | -6.243% |
| Chemed Corp. | 6 | 0 | 0 | 0 | €525.00 | €600.54 | 14.388% |
| Globus Medical A | 1 | 0 | 0 | 0 | €65.00 | - | - |
| LivaNova plc | 12 | 0 | 0 | 0 | €44.80 | €66.49 | 48.420% |
| Humana Inc. | 23 | 0 | 0 | 0 | €329.30 | €381.44 | 15.833% |
| Gilead Sciences Inc | 12 | 1 | 0 | 0 | €72.20 | €84.81 | 17.468% |
| Roche Holding AG ADR | 3 | 3 | 0 | 0 | €37.53 | €38.00 | 1.242% |
| GSK plc ADR | 5 | 0 | 0 | 0 | €39.00 | €49.33 | 26.480% |
| Centene Corp. | 26 | 0 | 0 | 0 | €73.06 | €82.38 | 12.753% |
| Ionis Pharmaceuticals Inc. | 28 | 6 | 0 | 0 | €43.08 | €56.72 | 31.666% |
| Geron Corp. | 15 | 0 | 0 | 0 | €3.98 | €5.52 | 38.779% |
| Smith & Nephew plc | 1 | 0 | 0 | 0 | €13.96 | - | - |
| Heron Therapeutics Inc. | 11 | 1 | 0 | 0 | €1.56 | €4.63 | 195.956% |
| Paul Hartmann AG | 4 | 0 | 0 | 0 | €197.50 | - | - |
| arGEN X BV | 1 | 0 | 0 | 0 | €467.60 | €470.00 | 0.513% |
| Bio-Techne Corp. | 9 | 0 | 0 | 0 | €67.50 | €75.80 | 12.301% |
| Healthequity Inc. | 2 | 0 | 0 | 0 | €71.50 | €82.25 | 15.035% |
| Charles River Labs Intl | 13 | 0 | 0 | 0 | €177.85 | €247.61 | 39.223% |
| Veeva Systems A | 2 | 0 | 0 | 0 | €195.35 | - | - |
| Incyte Corp. | 13 | 2 | 0 | 0 | €60.08 | €77.67 | 29.280% |